The purpose of the study: obtaining knowledge about the impact of Snoezelen® therapy on the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol. The main questions it aims to answer are: Does Snoezelen therapy improve the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol? The participant will participate in Snoezelen® therapy for 6 or 12 weeks, 2 times a week (30 minutes each session).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
outcomes in patients suffering from schizophrenia requiring institutional care - MOCA or ACE-III
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia requiring institutional care - BDI or GDS
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia requiring institutional care - Burns Anxiety Inventory
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia requiring institutional care - SWLS
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia requiring institutional care - Barthel Scale
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia requiring institutional care - blood test
Timeframe: From enrollment to the end of treatment at 12 weeks
Outcomes in patients suffering from schizophrenia - MOCA or ACE-III or CSSS Scale.
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia - PSYRATS
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia - BNSS
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia - Emotional state examination
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia - INTE
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients suffering from schizophrenia - blood test
Timeframe: From enrollment to the end of treatment at 12 weeks
outcomes in patients (women) addicted to alcohol MOCA or ACE-III
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - Emotional state
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - Anxiety levels - Burns Anxiety Inventory
Timeframe: From enrollment to the end of treatment at 6 weeks
outcomes in patients (women) addicted to alcohol - Anxiety levels - STAI
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - CISS
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - SWLS
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - INTE
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - blood test
Timeframe: From enrollment to the end of treatment at 6 weeks.
outcomes in patients (women) addicted to alcohol - follow up PACS Scale
Timeframe: 4 weeks after the end of study (follow-up), a telephone interview will be conducted with the use of short Penn Alcohol Craving Scale (PACS).